Tapentadol
Tapentadol is a centrally-acting synthetic analgesic used to treat moderate to severe pain. It works through dual mechanisms—acting as a mu-opioid receptor agonist and a norepinephrine reuptake inhibitor—to provide pain relief. This medication is typically prescribed when other pain treatments are insufficient.
Tapentadol is an opioid analgesic for moderate to severe pain that works through dual mechanisms of mu-opioid receptor activation and norepinephrine reuptake inhibition.
This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.
Key facts at a glance
- ATC
- N02AX06
- RxNorm
- 787390
- Generic
- Tapentadol
- Class
- atc-n02
- Brands
- Nucynta
- Availability
- rx
- Lactation
- unknown
- Routes
- oral
- Forms
- tablet, solution
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Dosage and administration
- Usual dose
- 50-100mg every 4-6 hours as needed
- Maximum
- consult physician
- Frequency
- every 4-6 hours
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- Not recommended for patients under 18 years
- Maximum
- consult physician
- Frequency
- N/A
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
- Usual dose
- 50mg every 6-8 hours
- Maximum
- consult physician
- Frequency
- every 6-8 hours
- Instructions
- Follow physician instructions
- Duration limits
- as prescribed
- Monitoring
- standard
Overdose information
Special Populations
9 groupspregnancy
first trimesteravoid if possible
avoid use during pregnancy unless benefits outweigh risks
regular fetal monitoring
Use of this medication in this population requires careful consideration of risks and benefits.
pregnancy
second trimesteruse lowest effective dose
use only if benefits outweigh risks
fetal growth monitoring
Use with caution and monitor for adverse effects.
pregnancy
third trimesteravoid if possible
avoid use near delivery due to risk of neonatal respiratory depression
close fetal monitoring and assessment of newborn
Use of this medication in this population requires careful consideration of risks and benefits.
lactation
breastfeedingavoid
do not breastfeed during tapentadol treatment
infant monitoring for sedation and respiratory depression
Use of this medication in this population requires careful consideration of risks and benefits.
geriatric
elderlyreduce initial dose by 50%
start with lowest effective dose, monitor closely for adverse effects
monitor for sedation, respiratory depression, falls and cognitive impairment
Use with caution and monitor for adverse effects.
pediatric_age
children adolescentsnot recommended
not recommended for patients under 18 years of age
not applicable - avoid use
Use of this medication in this population requires careful consideration of risks and benefits.
renal_impairment
severe renal impairmentreduce dose frequency
use with caution in severe renal impairment; consider dose reduction
monitor renal function and for accumulation of metabolites
Use with caution and monitor for adverse effects.
hepatic_impairment
moderate hepatic impairmentreduce dose by 50%
use with caution; dose reduction recommended
monitor liver function and for increased sedation
Use with caution and monitor for adverse effects.
hepatic_impairment
severe hepatic impairmentavoid
not recommended in severe hepatic impairment
not applicable - avoid use
Use of this medication in this population requires careful consideration of risks and benefits.
Statistics and clinical data
FDA approval year
FDA approval for Tapentadol (Nucynta)
Drug class
Pharmacological classification
Mechanism of action
Dual action analgesic
Common uses
Therapeutic indications
Treatment of moderate to severe acute pain and chronic pain conditions when other analgesics are inadequate.
Tapentadol produces analgesia through two complementary mechanisms: activation of mu-opioid receptors (similar to traditional opioids) and inhibition of norepinephrine reuptake (enhancing descending pain inhibition pathways).
Carries risks associated with opioid use including dependence, addiction, respiratory depression, and potential for abuse. Should be used with caution and typically reserved for patients who do not respond to non-opioid analgesics. Requires careful dose titration and monitoring.
Contraindications
Conditions and patient states where this medication should be avoided or used with caution.
Do not use (1)
Known allergy to this medication or its components
Use caution (1)
Consult healthcare provider for benefits vs risks assessment
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy